Alexander Shimabukuro‐Vornhagen

COVID‐19 associated pulmonary aspergillosis

Philipp Koehler, Oliver A. Cornely, Bernd W. Böttiger et al. · Mycoses · 2020 · 551 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma

Axel Lechner, Hans Schlößer, Martin Thelen et al. · OncoImmunology · 2019 · 167 citations · Full text

Life Sciences, Immunology, Oncology +17

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19

Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 151 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 137 citations · Full text

Medicine, Critical Care Nursing, Critical Care Medicine +6